vs

Side-by-side financial comparison of Strive, Inc. (ASST) and SeaStar Medical Holding Corp (ICU). Click either name above to swap in a different company.

SeaStar Medical Holding Corp is the larger business by last-quarter revenue ($420.0K vs $255.0K, roughly 1.6× Strive, Inc.). SeaStar Medical Holding Corp runs the higher net margin — -691.4% vs -75406.7%, a 74715.2% gap on every dollar of revenue. On growth, SeaStar Medical Holding Corp posted the faster year-over-year revenue change (526.9% vs -74.1%).

Strive Asset Management is an American investment management firm founded in 2022. The firm operates mutual funds, exchange-traded products (ETPs), and wealth management services. Headquartered in Columbus, Ohio, it operates as a subsidiary of Strive Enterprises, Inc. and is registered with the U.S. Securities and Exchange Commission (SEC) as an investment adviser.

ICU Medical, Inc. is a medical technology company based in San Clemente, California. ICU Medical products are designed to prevent bloodstream infections and protect healthcare workers from exposure to infectious diseases or hazardous drugs. ICU Medical product line includes intravenous therapy (IV) products, pumps, needle-free vascular access devices, custom infusion sets, closed system hazardous drug handling devices and systems, sensor catheters, needle-free closed blood sampling systems, a...

ASST vs ICU — Head-to-Head

Bigger by revenue
ICU
ICU
1.6× larger
ICU
$420.0K
$255.0K
ASST
Growing faster (revenue YoY)
ICU
ICU
+601.0% gap
ICU
526.9%
-74.1%
ASST
Higher net margin
ICU
ICU
74715.2% more per $
ICU
-691.4%
-75406.7%
ASST

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ASST
ASST
ICU
ICU
Revenue
$255.0K
$420.0K
Net Profit
$-192.3M
$-2.9M
Gross Margin
97.1%
Operating Margin
-17288.6%
-718.6%
Net Margin
-75406.7%
-691.4%
Revenue YoY
-74.1%
526.9%
Net Profit YoY
-2726.9%
34.3%
EPS (diluted)
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASST
ASST
ICU
ICU
Q4 25
$420.0K
Q3 25
$255.0K
$183.0K
Q2 25
$173.3K
$338.0K
Q1 25
$170.7K
$293.0K
Q4 24
$212.8K
$67.0K
Q3 24
$984.0K
$68.0K
Q2 24
$93.0K
$0
Q1 24
$124.8K
$0
Net Profit
ASST
ASST
ICU
ICU
Q4 25
$-2.9M
Q3 25
$-192.3M
$-3.5M
Q2 25
$-8.9M
$-2.0M
Q1 25
$-3.7M
$-3.8M
Q4 24
$-4.1M
$-4.4M
Q3 24
$-6.8M
$-4.5M
Q2 24
$-5.9M
$-3.2M
Q1 24
$-4.8M
$-12.7M
Gross Margin
ASST
ASST
ICU
ICU
Q4 25
97.1%
Q3 25
92.3%
Q2 25
92.0%
Q1 25
100.0%
Q4 24
100.0%
Q3 24
100.0%
Q2 24
Q1 24
Operating Margin
ASST
ASST
ICU
ICU
Q4 25
-718.6%
Q3 25
-17288.6%
-1955.7%
Q2 25
-1553.9%
-519.5%
Q1 25
-970.5%
-1304.4%
Q4 24
-5889.5%
-7114.9%
Q3 24
-712.4%
-6552.9%
Q2 24
-1857.2%
Q1 24
-1110.9%
Net Margin
ASST
ASST
ICU
ICU
Q4 25
-691.4%
Q3 25
-75406.7%
-1897.3%
Q2 25
-5122.4%
-592.3%
Q1 25
-2195.6%
-1287.4%
Q4 24
-1935.5%
-6595.5%
Q3 24
-691.3%
-6585.3%
Q2 24
-6313.1%
Q1 24
-3837.7%
EPS (diluted)
ASST
ASST
ICU
ICU
Q4 25
Q3 25
$-0.22
Q2 25
$-0.17
$-0.18
Q1 25
$-0.13
$-0.44
Q4 24
$-5.62
$0.23
Q3 24
$-3.06
$-1.10
Q2 24
$-0.58
$-1.03
Q1 24
$-0.49
$-4.73

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASST
ASST
ICU
ICU
Cash + ST InvestmentsLiquidity on hand
$109.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$779.4M
$10.4M
Total Assets
$792.6M
$14.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASST
ASST
ICU
ICU
Q4 25
Q3 25
$109.1M
Q2 25
$2.5M
Q1 25
$4.2M
Q4 24
$6.2M
Q3 24
$2.1M
Q2 24
$1.9M
Q1 24
$1.9M
Total Debt
ASST
ASST
ICU
ICU
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$0
Q2 24
$0
Q1 24
$1.1M
Stockholders' Equity
ASST
ASST
ICU
ICU
Q4 25
$10.4M
Q3 25
$779.4M
$11.5M
Q2 25
$10.7M
$3.3M
Q1 25
$19.6M
$565.0K
Q4 24
$23.3M
$-2.2M
Q3 24
$27.5M
$-2.1K
Q2 24
$5.4M
$-6.9M
Q1 24
$11.3M
$-4.5M
Total Assets
ASST
ASST
ICU
ICU
Q4 25
$14.2M
Q3 25
$792.6M
$15.5M
Q2 25
$3.3M
$8.4M
Q1 25
$5.0M
$7.6M
Q4 24
$28.2M
$4.7M
Q3 24
$2.6M
$4.6M
Q2 24
$2.4M
$3.5M
Q1 24
$2.1M
$7.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASST
ASST
ICU
ICU
Operating Cash FlowLast quarter
$-14.0M
$-4.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASST
ASST
ICU
ICU
Q4 25
$-4.1M
Q3 25
$-14.0M
$-3.8M
Q2 25
$-1.7M
$-3.0M
Q1 25
$-1.6M
$-2.7M
Q4 24
$-21.6M
$-4.7M
Q3 24
$-13.2M
$-5.0M
Q2 24
$-1.3M
$-2.8M
Q1 24
$-1.0M
$-3.5M
Free Cash Flow
ASST
ASST
ICU
ICU
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$-21.6M
Q3 24
$-13.4M
Q2 24
$-1.3M
Q1 24
$-1.1M
FCF Margin
ASST
ASST
ICU
ICU
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-10161.2%
Q3 24
-1360.3%
Q2 24
-1379.4%
Q1 24
-844.7%
Capex Intensity
ASST
ASST
ICU
ICU
Q4 25
Q3 25
0.0%
Q2 25
Q1 25
Q4 24
11.3%
Q3 24
18.8%
Q2 24
3.1%
Q1 24
9.5%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons